Literature DB >> 23584561

Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome.

Alexandra F Freeman1, Ellen D Renner, Carolyn Henderson, Anne Langenbeck, Kenneth N Olivier, Amy P Hsu, Beate Hagl, Annette Boos, Joie Davis, Beatriz E Marciano, Lisa Boris, Pamela Welch, Julie Sawalle-Belohradsky, Bernd H Belohradsky, King F Kwong, Steven M Holland.   

Abstract

PURPOSE: Autosomal dominant hyper-IgE syndrome (AD-HIES) due to heterozygous STAT3 mutation is a primary immunodeficiency characterized by eczema, elevated serum IgE, recurrent infections, and connective tissue and skeletal findings. Healing of pneumonias is often abnormal with formation of pneumatoceles and bronchiectasis. We aimed to explore whether healing after lung surgery is also aberrant.
METHODS: We retrospectively analyzed the medical records of 32 patients with AD-HIES who received lung surgery for the management of pulmonary infections from 1960 to 2011. We collected information including patient demographics, STAT3 mutation status, clinical history, surgical and medical procedures performed, complications, related medical treatments, and outcomes.
RESULTS: More than 50% of lung surgeries had associated complications, with the majority being prolonged bronchopleural fistulae. These fistulae often led to empyemas that necessitated additional interventions including prolonged antibiotics, prolonged thoracostomy tube drainage and re-operations.
CONCLUSION: Lung surgery in AD-HIES patients is associated with high complication rates. STAT3 mutations likely lead to abnormalities in tissue remodelling that are further exacerbated by infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23584561     DOI: 10.1007/s10875-013-9890-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  17 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  Predictive and prognostic value of preoperative symptoms in the surgical treatment of pulmonary aspergilloma.

Authors:  Dariusz Sagan; Kazimierz Goździuk; Elzbieta Korobowicz
Journal:  J Surg Res       Date:  2010-08-11       Impact factor: 2.192

3.  Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy.

Authors:  Dariusz Sagan; Kazimierz Goździuk
Journal:  Ann Thorac Surg       Date:  2010-05       Impact factor: 4.330

Review 4.  Epithelial repair mechanisms in the lung.

Authors:  Lynn M Crosby; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-02       Impact factor: 5.464

5.  Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.

Authors:  Evgenios Goussetis; Ioulia Peristeri; Vasiliki Kitra; Joanne Traeger-Synodinos; Maria Theodosaki; Katerina Psarra; Maria Kanariou; Fotini Tzortzatou-Stathopoulou; Eftichia Petrakou; Irene Fylaktou; Emmanuel Kanavakis; Stelios Graphakos
Journal:  J Allergy Clin Immunol       Date:  2010-07-02       Impact factor: 10.793

6.  Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).

Authors:  Jennifer Heimall; Joie Davis; Pamela A Shaw; Amy P Hsu; Wenjuan Gu; Pam Welch; Steven M Holland; Alexandra F Freeman
Journal:  Clin Immunol       Date:  2011-01-14       Impact factor: 3.969

7.  STAT3 mutations in the hyper-IgE syndrome.

Authors:  Steven M Holland; Frank R DeLeo; Houda Z Elloumi; Amy P Hsu; Gulbu Uzel; Nina Brodsky; Alexandra F Freeman; Andrew Demidowich; Joie Davis; Maria L Turner; Victoria L Anderson; Dirk N Darnell; Pamela A Welch; Douglas B Kuhns; David M Frucht; Harry L Malech; John I Gallin; Scott D Kobayashi; Adeline R Whitney; Jovanka M Voyich; James M Musser; Cristina Woellner; Alejandro A Schäffer; Jennifer M Puck; Bodo Grimbacher
Journal:  N Engl J Med       Date:  2007-09-19       Impact factor: 91.245

8.  Causes of death in hyper-IgE syndrome.

Authors:  Alexandra F Freeman; David E Kleiner; Hari Nadiminti; Joie Davis; Martha Quezado; Victoria Anderson; Jennifer M Puck; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2007-03-01       Impact factor: 10.793

9.  Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.

Authors:  Marie-Olivia Chandesris; Isabelle Melki; Angels Natividad; Anne Puel; Claire Fieschi; Ling Yun; Caroline Thumerelle; Eric Oksenhendler; David Boutboul; Caroline Thomas; Cyrille Hoarau; Yvon Lebranchu; Jean-Louis Stephan; Celine Cazorla; Nathalie Aladjidi; Marguerite Micheau; François Tron; André Baruchel; Vincent Barlogis; Gilles Palenzuela; Catherine Mathey; Stéphane Dominique; Gérard Body; Martine Munzer; Fanny Fouyssac; Rolland Jaussaud; Brigitte Bader-Meunier; Nizar Mahlaoui; Stéphane Blanche; Marianne Debré; Muriel Le Bourgeois; Virginie Gandemer; Nathalie Lambert; Virginie Grandin; Stéphanie Ndaga; Corinne Jacques; Chantal Harre; Monique Forveille; Marie-Alexandra Alyanakian; Anne Durandy; Christine Bodemer; Felipe Suarez; Olivier Hermine; Olivier Lortholary; Jean-Laurent Casanova; Alain Fischer; Capucine Picard
Journal:  Medicine (Baltimore)       Date:  2012-07       Impact factor: 1.889

10.  Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome.

Authors:  Elizabeth Melia; Alexandra F Freeman; Yvonne R Shea; Amy P Hsu; Steven M Holland; Kenneth N Olivier
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793

View more
  15 in total

1.  Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome.

Authors:  Natalia I Dmitrieva; Avram D Walts; Dai Phuong Nguyen; Alex Grubb; Xue Zhang; Xujing Wang; Xianfeng Ping; Hui Jin; Zhen Yu; Zu-Xi Yu; Dan Yang; Robin Schwartzbeck; Clifton L Dalgard; Beth A Kozel; Mark D Levin; Russell H Knutsen; Delong Liu; Joshua D Milner; Diego B López; Michael P O'Connell; Chyi-Chia Richard Lee; Ian A Myles; Amy P Hsu; Alexandra F Freeman; Steven M Holland; Guibin Chen; Manfred Boehm
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome.

Authors:  Claire E Bocchini; Karen Nahmod; Panagiotis Katsonis; Sang Kim; Moses M Kasembeli; Alexandra Freeman; Olivier Lichtarge; George Makedonas; David J Tweardy
Journal:  Blood       Date:  2016-10-31       Impact factor: 22.113

3.  A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Geetha Rao; Tanwir Habib; Danielle T Avery; Alain Lefèvre-Utile; Marie-Olivia Chandesris; Aziz Belkadi; Maya Chrabieh; Hanan Alwaseem; Virginie Grandin; Françoise Sarrot-Reynauld; Agathe Sénéchal; Olivier Lortholary; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Capucine Picard; Anne Puel; Vivien Béziat; Qian Zhang; Laurent Abel; Henrik Molina; Nico Marr; Stuart G Tangye; Jean-Laurent Casanova; Bertrand Boisson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

4.  Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

Authors:  Yael Gernez; Alexandra F Freeman; Steven M Holland; Elizabeth Garabedian; Niraj C Patel; Jennifer M Puck; Kathleen E Sullivan; Javeed Akhter; Elizabeth Secord; Karin Chen; Rebecca Buckley; Elie Haddad; Hans D Ochs; Ramsay Fuleihan; John Routes; Mica Muskat; Patricia Lugar; Julien Mancini; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-19

5.  Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.

Authors:  Khaled Z Abd-Elmoniem; Nadine Ramos; Saami K Yazdani; Ahmed M Ghanem; Steven M Holland; Alexandra F Freeman; Ahmed M Gharib
Journal:  Atherosclerosis       Date:  2017-01-19       Impact factor: 5.162

6.  TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.

Authors:  Ian A Myles; Erik D Anderson; Noah J Earland; Kol A Zarember; Inka Sastalla; Kelli W Williams; Portia Gough; Ian N Moore; Sundar Ganesan; Cedar J Fowler; Arian Laurence; Mary Garofalo; Douglas B Kuhns; Mark D Kieh; Arhum Saleem; Pamela A Welch; Dirk A Darnell; John I Gallin; Alexandra F Freeman; Steven M Holland; Sandip K Datta
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

7.  Hemoptysis in a Patient with Elevated Immunoglobulin E.

Authors:  Yael Gernez; Angela Tsuang; Tukisa D Smith; Khurram Shahjehan; Yiqun Hui; Paul J Maglione; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-29

Review 8.  Hyper-IgE Syndromes and the Lung.

Authors:  Alexandra F Freeman; Kenneth N Olivier
Journal:  Clin Chest Med       Date:  2016-06-10       Impact factor: 2.878

9.  Pulmonary Infections and Surgical Complications in a Young Girl with Signal Transducer and Activator of Transcription 3 Loss-of-Function Mutation Hyperimmunoglobulin E Syndrome: A Case Report.

Authors:  Crhistian Toribio-Dionicio; Dania Cubas-Guzmán; Pedro Guerra-Canchari; Vanuza García-Sánchez; Wilmer Córdova-Calderón
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-03       Impact factor: 1.349

10.  Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Peng Zhang; Franck Rapaport; Qian Zhang; Anne Puel; Vivien Béziat; Jean-Laurent Casanova; Bertrand Boisson; Takaki Asano; András N Spaan; Juan Li; Wei-Te Lei; Simon J Pelham; David Hum; Maya Chrabieh; Ji Eun Han; Antoine Guérin; Joseph Mackie; Sudhir Gupta; Biman Saikia; Jamila E I Baghdadi; Ilham Fadil; Aziz Bousfiha; Tanwir Habib; Nico Marr; Luckshman Ganeshanandan; Jane Peake; Luke Droney; Andrew Williams; Fatih Celmeli; Nevin Hatipoglu; Tayfun Ozcelik; Capucine Picard; Laurent Abel; Stuart G Tangye; Stéphanie Boisson-Dupuis
Journal:  J Exp Med       Date:  2021-06-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.